June 22, 2017
Session 1 - A Brave New World in Coagulation Therapies
Gene therapy in hemophilia: current status and future prospects
Presentation by Dr. Jerome Teitel
Do we really need FVIII and FIX? Alternative strategies to treat hemophilia
Presentation by Dr. David Lillicrap
Inhibitor management: what's new?
Presentation by Dr. Manuel Carcao
Can we extend far enough? Extended half-life FVIII and IX coagulation factors in Canada
Presentation by Dr. Shannon Jackson
Session 2 - The Canadian Bleeding Disorders Registry
CBDR: 15 of 23 centres now “live”
Presented by Arun Keepanasseril
Session 3 - Women and Bleeding Disorders
What can we learn by studying desmopressin responses in hemophilia carriers?
Presented by Dr. Paula James
Excessive bleeding in women: spotlight on hemophilia carriers
Presented by Dr. Michelle Sholzberg